Drug Type Enzyme |
Synonyms alpha-glucosidase fusion protein(JCR Pharmaceuticals), JR-162 |
Target |
Action stimulants |
Mechanism α-glucosidase stimulants(Acidic alpha-glucosidase stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glycogen Storage Disease Type II | Preclinical | Japan | 19 May 2021 |